| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 172 |
| 1 | DEXAMETHASONE 1.5 MG | 172 |
| 2 | PREDNISOLONE | 124 |
| 3 | PREDNISOLONE ORAL | 124 |
| 4 | PREDNISOLONE ORAL SOLUTION | 124 |
| 5 | PREDNISONE | 112 |
| 6 | METHOTREXATE SODIUM | 108 |
| 7 | LENALIDOMIDE | 106 |
| 8 | TACROLIMUS | 102 |
| 9 | METHOTREXATE | 95 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISATUXIMAB | 18 | 0.0031 |
| 1 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 14 | 0.0031 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 23 | 0.0028 |
| 3 | ELOTUZUMAB | 14 | 0.0027 |
| 4 | VALGANCICLOVIR | 24 | 0.0013 |
| 5 | SIROLIMUS | 15 | 0.0011 |
| 6 | BORTEZOMIB | 89 | 0.0010 |
| 7 | HUMAN IMMUNOGLOBULIN G | 20 | 0.0010 |
| 8 | ERGOCALCIFEROL | 28 | 0.0009 |
| 9 | AMPHOTERICIN B | 12 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 457 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 167 |
| 2 | Thalidomide Analog [EPC] | 141 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 105 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 97 |
| 5 | Alkylating Drug [EPC] | 96 |
| 6 | Proteasome Inhibitor [EPC] | 95 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 92 |
| 8 | Kinase Inhibitor [EPC] | 85 |
| 9 | Loop Diuretic [EPC] | 79 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CXC Chemokine Receptor 4 Antagonist [EPC] | 1 | 0.1250 |
| 1 | Interleukin-5 Antagonist [EPC] | 16 | 0.0233 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 60 | 0.0103 |
| 3 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 14 | 0.0027 |
| 4 | CD19-directed Cytolytic Antibody [EPC] | 2 | 0.0023 |
| 5 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 6 | Nuclear Export Inhibitor [EPC] | 12 | 0.0014 |
| 7 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 27 | 0.0012 |
| 9 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |